Literature DB >> 9665300

Purulent pleurisy caused by Campylobacter lari.

B Bruneau1, L Burc, C Bizet, N Lambert-Zechovsky, C Branger.   

Abstract

An 80-year-old debilitated patient developed purulent pleurisy caused by a Campylobacter lari isolate. The patient underwent surgical drainage and received antibiotic therapy with amoxicillin/clavulanic acid and ofloxacin. Antibiotic susceptibility data showed that the isolate was fully sensitive to clarithromycin, tetracycline, aminoglycosides. and ciprofloxacin. Imipenem and amoxicillin plus clavulanic acid were the most active beta-lactam agents.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9665300     DOI： 10.1007/bf01691115

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


  16 in total

1.  Campylobacter laridis colitis in a human immunodeficiency virus-positive patient treated with a quinolone.

Authors:  T G Evans; D Riley
Journal:  Clin Infect Dis       Date:  1992-07       Impact factor: 9.079

2.  Reactive arthritis as a complication of Campylobacter lari enteritis.

Authors:  J Goudswaard; L Sabbe; W te Winkel
Journal:  J Infect       Date:  1995-09       Impact factor: 6.072

3.  Chronic diarrhea and bacteremia caused by Campylobacter lari in a neonate.

Authors:  C H Chiu; C Y Kuo; J T Ou
Journal:  Clin Infect Dis       Date:  1995-09       Impact factor: 9.079

4.  Genotypic diversity of Campylobacter lari isolated from mussels and oysters in The Netherlands.

Authors:  H P Endtz; J S Vliegenthart; P Vandamme; H W Weverink; N P van den Braak; H A Verbrugh; A van Belkum
Journal:  Int J Food Microbiol       Date:  1997-01       Impact factor: 5.277

5.  Enteritis associated with Campylobacter laridis.

Authors:  A E Simor; L Wilcox
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

6.  Illness associated with Campylobacter laridis, a newly recognized Campylobacter species.

Authors:  R V Tauxe; C M Patton; P Edmonds; T J Barrett; D J Brenner; P A Blake
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

7.  Septicaemia caused by unusual Campylobacter species (C. laridis and C. mucosalis).

Authors:  C Söderström; C Schalén; M Walder
Journal:  Scand J Infect Dis       Date:  1991

8.  Emergence of resistance to erythromycin and fluoroquinolones in thermotolerant Campylobacter strains isolated from feces 1987-1991.

Authors:  J Reina; N Borrell; A Serra
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-12       Impact factor: 3.267

9.  '1001' Campylobacters: cultural characteristics of intestinal campylobacters from man and animals.

Authors:  M B Skirrow; J Benjamin
Journal:  J Hyg (Lond)       Date:  1980-12

10.  Urease-positive thermophilic Campylobacter (Campylobacter laridis variant) isolated from an appendix and from human feces.

Authors:  F Mégraud; D Chevrier; N Desplaces; A Sedallian; J L Guesdon
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948
View more
  2 in total

1.  Fatal case of Campylobacter lari prosthetic joint infection and bacteremia in an immunocompetent patient.

Authors:  Anja M Werno; John D Klena; Geoffrey M Shaw; David R Murdoch
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

2.  Fatal relapse of a purulent pleurisy caused by Campylobacter fetus subsp. fetus.

Authors:  Jean-Winoc Decousser; Valérie Prouzet-Mauléon; Christine Bartizel; Thomas Gin; Jean-Pierre Colin; Nicolas Fadel; C Holler; J Pollet; Francis Megraud
Journal:  J Clin Microbiol       Date:  2007-05-16       Impact factor: 5.948
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.